Cite
HARVARD Citation
Boyle, L. et al. (2014). A safety evaluation of canagliflozin: a first-in-class treatment for type 2 diabetes. Expert opinion on drug safety. pp. 1535-1544. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boyle, L. et al. (2014). A safety evaluation of canagliflozin: a first-in-class treatment for type 2 diabetes. Expert opinion on drug safety. pp. 1535-1544. [Online].